Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4920920

Cc1nc(C(=O)N(C)C2CCN(C)C2)cc2c(Nc3cccc4c3CCO4)c(C(N)=O)cnc12.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.45
MAP4K4 O95819 1/20 0.36
KCNH2 Q12809 4/20 0.35
CSF1R P07333 5/20 0.33
MAP4K1 Q92918 2/20 0.33
POLR1A O95602 1/20 0.33
PFKFB3 Q16875 1/20 0.33
MCHR1 Q99705 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
SCN5A Q14524 1/20 0.32
EED O75530 1/20 0.32
RBBP4 Q09028 1/20 0.32
SUZ12 Q15022 1/20 0.32
EZH2 Q15910 1/20 0.32
AEBP2 Q6ZN18 1/20 0.32
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4929251 0.91 PDE4B (0.48) PDE4BKCNH2CSF1RMTOR
Trifluoroacetic Acid SCHEMBL4930138 0.87 PDE4B (0.45) PDE4BMAP4K4PDE4APDE4CPDE4D
Trifluoroacetic Acid SCHEMBL4929976 0.85 PDE4B (0.51) PDE4BCSF1REEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4920764 0.84 PDE4B (0.49) PDE4BKCNH2CSF1RMAP4K1SCN5A
Trifluoroacetic Acid SCHEMBL4928901 0.84 PDE4B (0.48) PDE4BCSF1REEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4924249 0.82 PDE4B (0.48) PDE4B
Trifluoroacetic Acid SCHEMBL4929066 0.81 PDE4B (0.41) PDE4BKCNH2MAP4K1
Trifluoroacetic Acid SCHEMBL4926823 0.80 PDE4B (0.46) PDE4BKCNH2MAP4K1
SCHEMBL4928534 0.80 PDE4B (0.59) PDE4BCSF1REEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4929908 0.80 PDE4B (0.42) PDE4BKCNH2CSF1RMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors GLAXO GROUP LIMITED 2008-06-19 US claimed
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors GLAXO GROUP LIMITED 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors PDE4A, PDE3B, PDE4B PDE4B 3/4885MAP4K4 220/4885KCNH2 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.